Gary Walker
Expertise in
14
conditions

Dr. Gary Walker

Radiation Oncology | Otolaryngology
2946 East Banner Gateway Drive, 
Gilbert, AZ 
Accepting New Patients
Offers Telehealth
Referral may be required
Expertise in
14
conditions
2946 East Banner Gateway Drive, 
Gilbert, AZ 

Overview

Outside of caring for patients, I enjoy wheel-thrown pottery, camping, skiing and hiking.

Dr. Walker is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Bone Tumor, Lung Cancer, Pleuropulmonary Blastoma, and Chondrosarcoma.

Dr. Walker is board certified in American Board Of Radiology/Radiation Oncology and American Board Of Preventive Medicine/Clinical Informatics. He is actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 6 clinical trials. Dr. Walker is currently accepting new patients.

Graduate Institution

Baylor College Of Medicine, 2010

Residency

University of Texas MD Anderson Cancer Center, Radiation Oncology, 2015

Specialties

Radiation Oncology
Otolaryngology

Licenses

Radiology in TX

Board Certifications

American Board Of Radiology/Radiation Oncology
American Board Of Preventive Medicine/Clinical Informatics

Hospital Affiliations

Banner Gateway Medical Center

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

Banner MD Anderson Cancer Center at Banner Gateway Medical Center
2946 East Banner Gateway Drive, Gilbert, AZ 85234

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
External Beam Radiation to Eliminate Nominal Metastatic Disease (EXTEND): A Randomized Phase II Basket Trial Assessing the Efficacy of Upfront Local Consolidative Therapy (LCT) for Oligometastatic Disease
External Beam Radiation to Eliminate Nominal Metastatic Disease (EXTEND): A Randomized Phase II Basket Trial Assessing the Efficacy of Upfront Local Consolidative Therapy (LCT) for Oligometastatic Disease
Enrollment Status: Active_not_recruiting
Publish Date: June 12, 2026
Intervention Type: Procedure, Other
Study Phase: Phase 2
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug, Radiation, Biological
Study Phase: Phase 2
GRECO-2: A Randomized, Phase 2b Study of GC4711 in Combination With Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Unresectable or Borderline Resectable Nonmetastatic Pancreatic Cancer
GRECO-2: A Randomized, Phase 2b Study of GC4711 in Combination With Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Unresectable or Borderline Resectable Nonmetastatic Pancreatic Cancer
Enrollment Status: Terminated
Publish Date: May 21, 2024
Intervention Type: Drug
Study Drug: Drug GC4711
Study Phase: Phase 2
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 3
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 2
View 5 Less Clinical Trials

39 Total Publications

Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Solid Tumors: Primary Analysis of All Tumor-Histology Baskets of the Phase II Randomized EXTEND Trial.
Addition of Metastasis-Directed Therapy to Standard of Care for Oligometastatic Solid Tumors: Primary Analysis of All Tumor-Histology Baskets of the Phase II Randomized EXTEND Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 16, 2026
Similar Doctors
Expertise in
17
conditions
Dr. Steven Schild
Radiation Oncology
Expertise in
17
conditions
Dr. Steven Schild
Radiation Oncology
Referral may be required

Mayo Clinic Building Scottsdale

13400 E Shea Blvd, 
Scottsdale, AZ 
 (14.3 miles away)
480-301-8000
Languages Spoken:
English
See accepted insurances

Steven Schild is a Radiation Oncologist practicing medicine in Scottsdale, Arizona. Dr. Schild is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Prostate Cancer, Prostatectomy, and Tissue Biopsy.

Expertise in
30
conditions
Dr. Mark Varvares
Otolaryngology | Plastic Surgery
Expertise in
30
conditions
Dr. Mark Varvares
Otolaryngology | Plastic Surgery
Referral may be required

Massachusetts Eye And Ear

7301 E 2nd St Ste 300, 
Scottsdale, AZ 
 (13.5 miles away)
617-523-7900
Languages Spoken:
English
See accepted insurances

Mark Varvares is an Otolaryngologist and a Plastic Surgeon practicing medicine in Scottsdale, Arizona. Dr. Varvares is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Human Papillomavirus Infection, Head and Neck Squamous Cell Carcinoma (HNSCC), Glossectomy, and Tissue Biopsy.

Expertise in
14
conditions
Dr. David Lott
Otolaryngology
Expertise in
14
conditions
Dr. David Lott
Otolaryngology
Referral may be required

AZ - Cancer ENT

13400 E Shea Blvd, 
Scottsdale, AZ 
 (14.3 miles away)
480-604-2135
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Lott is an Otolaryngologist practicing medicine in Scottsdale, Arizona. Dr. Lott is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Spasmodic Dysphonia, Throat Cancer, Laryngeal Cancer, Laryngectomy, and Endoscopy.

Frequently Asked Questions about Dr. Gary Walker

Is Dr. Gary Walker a top-rated expert for Bone Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gary Walker is classified as an Distinguished expert for Bone Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gary Walker specialize in?

While Dr. Gary Walker is a Radiation Oncology, they have specific expertise in Bone Tumor, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Gary Walker participate in research or clinical trials?

Yes. Dr. Gary Walker has published 39 articles and abstracts on conditions like Bone Tumor. You can view a list of Dr. Gary Walker's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gary Walker accept my insurance?

Dr. Gary Walker accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Walker's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 54 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile